| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.
|
N Engl J Med
|
2003
|
4.88
|
|
2
|
Identifying distinct classes of bladder carcinoma using microarrays.
|
Nat Genet
|
2002
|
3.82
|
|
3
|
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.
|
Clin Cancer Res
|
2009
|
3.08
|
|
4
|
Molecular staging for survival prediction of colorectal cancer patients.
|
J Clin Oncol
|
2005
|
2.88
|
|
5
|
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.
|
Cancer Res
|
2009
|
2.80
|
|
6
|
Preferential response of cancer cells to zebularine.
|
Cancer Cell
|
2004
|
2.39
|
|
7
|
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.
|
Nat Genet
|
2006
|
2.33
|
|
8
|
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.
|
Mol Cell Proteomics
|
2008
|
2.24
|
|
9
|
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.
|
Clin Cancer Res
|
2007
|
1.87
|
|
10
|
Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidine.
|
Cancer Res
|
2002
|
1.71
|
|
11
|
Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.
|
Clin Cancer Res
|
2007
|
1.68
|
|
12
|
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.
|
Int J Cancer
|
2011
|
1.65
|
|
13
|
Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers.
|
Clin Cancer Res
|
2011
|
1.46
|
|
14
|
Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
|
Clin Cancer Res
|
2002
|
1.44
|
|
15
|
DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
|
Clin Cancer Res
|
2008
|
1.44
|
|
16
|
Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs.
|
BMC Genomics
|
2011
|
1.39
|
|
17
|
Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells.
|
Diabetes
|
2009
|
1.39
|
|
18
|
High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors.
|
Cancer Res
|
2005
|
1.34
|
|
19
|
Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays.
|
J Natl Cancer Inst
|
2002
|
1.34
|
|
20
|
DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer.
|
J Clin Oncol
|
2013
|
1.30
|
|
21
|
A molecular signature in superficial bladder carcinoma predicts clinical outcome.
|
Clin Cancer Res
|
2005
|
1.28
|
|
22
|
Distinct expression profile in fumarate-hydratase-deficient uterine fibroids.
|
Hum Mol Genet
|
2005
|
1.26
|
|
23
|
The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays.
|
Blood
|
2003
|
1.24
|
|
24
|
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer.
|
J Mol Med (Berl)
|
2008
|
1.16
|
|
25
|
Candidate driver genes in microsatellite-unstable colorectal cancer.
|
Int J Cancer
|
2011
|
1.08
|
|
26
|
Carbonic anhydrase IX is highly expressed in hereditary nonpolyposis colorectal cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.00
|
|
27
|
Proteome profiling of corneal epithelium and identification of marker proteins for keratoconus, a pilot study.
|
Exp Eye Res
|
2005
|
0.99
|
|
28
|
A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine.
|
Clin Cancer Res
|
2013
|
0.99
|
|
29
|
Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population.
|
Fam Cancer
|
2008
|
0.97
|
|
30
|
The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population.
|
BMC Med Genet
|
2008
|
0.97
|
|
31
|
Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.
|
Eur J Hum Genet
|
2006
|
0.97
|
|
32
|
Isolation of microarray-grade total RNA, microRNA, and DNA from a single PAXgene blood RNA tube.
|
J Mol Diagn
|
2007
|
0.96
|
|
33
|
EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer.
|
Cancer Res
|
2003
|
0.94
|
|
34
|
Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling.
|
J Mol Signal
|
2007
|
0.92
|
|
35
|
Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy.
|
Comp Funct Genomics
|
2004
|
0.92
|
|
36
|
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
|
Oncogene
|
2004
|
0.92
|
|
37
|
Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.
|
Thyroid
|
2008
|
0.92
|
|
38
|
Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation.
|
Cancer Res
|
2004
|
0.91
|
|
39
|
Profiling of circulating microRNAs for prostate cancer biomarker discovery.
|
Drug Deliv Transl Res
|
2014
|
0.91
|
|
40
|
Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer.
|
BMC Cancer
|
2011
|
0.90
|
|
41
|
Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells.
|
BMC Med Genomics
|
2008
|
0.89
|
|
42
|
Expression profiling confirms the role of endocytic receptor megalin in renal vitamin D3 metabolism.
|
Kidney Int
|
2002
|
0.87
|
|
43
|
Down-modulation of poly(ADP-ribose) polymerase-1 (PARP-1) in human TUR leukemia cells restores transcriptional responsiveness for differentiation and cell cycle arrest.
|
Eur J Cell Biol
|
2005
|
0.83
|
|
44
|
Combinations of urinary biomarkers for surveillance of patients with incident nonmuscle invasive bladder cancer: the European FP7 UROMOL project.
|
J Urol
|
2012
|
0.82
|
|
45
|
Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.
|
PLoS One
|
2012
|
0.77
|
|
46
|
Gene expression changes induced by bismuth in a macrophage cell line.
|
Cell Tissue Res
|
2005
|
0.77
|
|
47
|
Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males.
|
BMC Med Genomics
|
2010
|
0.76
|
|
48
|
Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder.
|
BMC Cancer
|
2008
|
0.75
|
|
49
|
Mutation analysis of MYH11 in acute myeloid leukemia.
|
Leuk Lymphoma
|
2008
|
0.75
|
|
50
|
Transcriptional profile of Ki-Ras-induced transformation of thyroid cells.
|
Cancer Invest
|
2007
|
0.75
|